Basic Information
Basic information for ZNF213-AS1-226-47aa
Peptide Name ZNF213-AS1-226-47aa
Genome Position chr16:3131747-3131796,3133614-3133704[-]
Species Human
Peptide Sequence MGFHQVSQAGLELQTSRDPPASAFQSAGITGGDWTSEEGVGAPRTHS
Peptide Length 47
Unique No (ZNF213-AS1-202-47aa,ZNF213-AS1-204-47aa,ZNF213-AS1-206-47aa,ZNF213-AS1-210-47aa,ZNF213-AS1-213-47aa,ZNF213-AS1-215-47aa-1,ZNF213-AS1-216-47aa,ZNF213-AS1-217-47aa,ZNF213-AS1-218-47aa-2,ZNF213-AS1-220-47aa,ZNF213-AS1-221-47aa,ZNF213-AS1-222-47aa,ZNF213-AS1-223-47aa,ZNF213-AS1-224-47aa-1,ZNF213-AS1-225-47aa)
Grand Average of Hydropathicity -0.5532
Relative Molecular Mass 5686.04
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000263072;ZNF213-AS1
Transcript ID/Name ENST00000671396;ZNF213-AS1-226
Transcript Length 1355
Coding Ability 0.1926
DNA Sequence Corresponding to Peptide ATGGGGTTTCACCAGGTTAGCCAGGCTGGTCTTGAACTCCAGACCTCAAGGGATCCGCCTGCCTCAGCTTTCCAAAGTGCTGGGATTACAGGTGGAGACTGGACCTCAGAAGAGGGAGTGGGTGCCCCGAGAACTCACAGC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :